RSH 3.85% 2.7¢ respiri limited

Hi Lucasq,From my experience with SaaS companies a recurring...

  1. 466 Posts.
    lightbulb Created with Sketch. 213
    Hi Lucasq,
    From my experience with SaaS companies a recurring revenue multiple of 5-10 is fair as they establish themselves, then if they become a key dominant player with a high profit margin, the multiple can easily increase to 15-20x.From memory Dexcom (NASDAQ: DXCM), who has done in diabetes, what we are attempting to do in asthma trades on a revenue multiple of ~20x (DXCM market cap of 22 billion USD)
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.